RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 111 filers reported holding RAPT THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.65 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,868,562 | +104.7% | 1,315,798 | +130.3% | 2.39% | -13.1% |
| Q2 2023 | $10,682,057 | +34.5% | 571,233 | +32.0% | 2.74% | -60.6% |
| Q1 2023 | $7,943,715 | -7.3% | 432,900 | 0.0% | 6.97% | -13.1% |
| Q4 2022 | $8,571,420 | -17.7% | 432,900 | 0.0% | 8.02% | -17.1% |
| Q3 2022 | $10,416,000 | +31.8% | 432,900 | 0.0% | 9.67% | +43.9% |
| Q2 2022 | $7,900,000 | -17.0% | 432,900 | 0.0% | 6.72% | +21.5% |
| Q1 2022 | $9,519,000 | -40.1% | 432,900 | 0.0% | 5.53% | -38.8% |
| Q4 2021 | $15,900,000 | -19.4% | 432,900 | -31.8% | 9.04% | -5.7% |
| Q3 2021 | $19,722,000 | -15.7% | 635,177 | -13.7% | 9.59% | +26.3% |
| Q2 2021 | $23,391,000 | +43.2% | 735,801 | 0.0% | 7.59% | +38.9% |
| Q1 2021 | $16,335,000 | +12.4% | 735,801 | 0.0% | 5.46% | +77.7% |
| Q4 2020 | $14,532,000 | – | 735,801 | – | 3.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ponoi Management, LLC | 1,599,417 | $58,747,000 | 54.16% |
| KPCB XV Associates, LLC | 1,297,063 | $47,641,000 | 37.58% |
| Ponoi II Management, LLC | 145,401 | $5,341,000 | 9.70% |
| Euclidean Capital LLC | 432,900 | $15,900,000 | 9.04% |
| Column Group LLC | 1,402,008 | $51,496,000 | 7.00% |
| AJU IB Investment Co., Ltd. | 99,503 | $3,655,000 | 5.09% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,148,321 | $42,178,000 | 4.85% |
| Ghost Tree Capital, LLC | 350,000 | $12,856,000 | 4.61% |
| Velan Capital Investment Management LP | 110,000 | $4,040,000 | 3.14% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 443,619 | $16,294,000 | 2.28% |